Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPP: Skin Toxicity Treatment in mCRC with Panitumumab
NCT00332163Phase 2Completed
- Sponsor
- Amgen
- Start
- Apr 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of doxycycline, Alkindi Sprinkle in Skin Toxicity, sponsored by Amgen. Started Apr 2006; status: completed.
02
Drugs
doxycyclineAlkindi Sprinkle
03
Conditions
Skin Toxicity
Beyond the preview
Go deeper on NCT00332163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332163.